Valeo Financial Advisors’s AnaptysBio ANAB Stock Holding History

Valeo Financial Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,275	Closed	-$92K	–	580
2021 Q1	$92K	Hold	4,275	–	–	﹤0.01%	654
2020 Q4	$92K	Hold	4,275	–	–	﹤0.01%	597
2020 Q3	$63K	Hold	4,275	–	–	0.01%	589
2020 Q2	$96K	Hold	4,275	–	–	0.01%	515
2020 Q1	$65K	Hold	4,275	–	–	0.01%	526
2019 Q4	$69K	Buy	4,275 +3,600	+533%	+$85.1K	0.01%	541
2019 Q3	$24K	Hold	675	–	–	﹤0.01%	796
2019 Q2	$38K	Hold	675	–	–	﹤0.01%	677
2019 Q1	$49K	Hold	675	–	–	0.01%	557
2018 Q4	$43K	Hold	675	–	–	0.01%	528
2018 Q3	$50K	Hold	675	–	–	0.01%	544
2018 Q2	$55K	Hold	675	–	–	0.01%	521
2018 Q1	$70K	Hold	675	–	–	0.01%	431
2017 Q4	$68K	Sell	675 -1,025	-60%	-$75.5K	0.01%	417
2017 Q3	$59K	Buy	+1,700	New	+$45.9K	0.01%	381

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Valeo Financial Advisors's ANAB Position: Q2 2021 in Review

Valeo Financial Advisors sold out of AnaptysBio (ANAB) in Q2 2021, closing a stake of 4,275 shares — an estimated $92K sold.

Valeo Financial Advisors first reported a position in ANAB in Q3 2017 and held it in 15 quarters. The position peaked at $96K in Q2 2020. 122 funds tracked by Wall St. Rank hold ANAB as of Q2 2021.

Valeo Financial Advisors reported no remaining AnaptysBio position as of Q2 2021 after selling out during the quarter.
Valeo Financial Advisors sold 4,275 AnaptysBio shares in Q2 2021, an estimated $92K.
Valeo Financial Advisors first reported a position in AnaptysBio in Q3 2017 and held it in 15 quarters.
Valeo Financial Advisors's AnaptysBio position peaked at $96K in Q2 2020.
122 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.